HitGen Inc. (SHA:688222)
China · Delayed Price · Currency is CNY 44.69
+1.01 (2.31%)
At close: Sep 30, 2026
HitGen Employees
HitGen had 706 employees as of June 30, 2026. The number of employees increased by 160 or 29.30% since the number was reported on December 31, 2025.
Employees
706
Change
160
Growth
29.30%
Revenue / Employee
912.94K CNY
Profits / Employee
198.50K CNY
Market Cap
17.91B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 706 | 160 | 29.30% |
| Dec 31, 2025 | 546 | 63 | 13.04% |
| Dec 31, 2024 | 483 | 31 | 6.86% |
| Dec 31, 2023 | 452 | -56 | -11.02% |
| Dec 31, 2022 | 508 | 37 | 7.86% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Xiamen Amoytop Biotech | 3,640 |
| Yili Chuanning Biotechnology | 3,126 |
| Nanjing Vazyme Biotech | 3,002 |
| Shanghai Medicilon | 2,780 |
| Anhui Anke Biotechnology (Group) | 2,505 |
| Sinocelltech Group | 2,200 |
| GemPharmatech | 1,692 |
| BrightGene Bio-Medical Technology | 1,199 |